Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor R Cushman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 11, 2019
Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United StatesVivek Verma, Waqar Haque, Taylor R Cushman, et al.
Journal of Thoracic Disease|March 30, 2018
Combining radiation plus immunotherapy to improve systemic immune responseTaylor R Cushman, Daniel Gomez, Rachit Kumar, et al.
Future Oncology (London, England)|February 19, 2020
Management and outcomes of primary anorectal melanoma in the United StatesHari Menon, Roshal R Patel, Taylor R Cushman, et al.
Clinical Lung Cancer|October 11, 2020
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United StatesTaylor R Cushman, Bernard Jones, David Akhavan, et al.
Future Oncology (London, England)|April 18, 2020
Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalitiesHari Menon, Roshal R Patel, Ethan B Ludmir, et al.
Clinical Lung Cancer|August 17, 2018
Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung CancerVivek Verma, Caitlin A Schonewolf, Taylor R Cushman, et al.
Frontiers in Immunology|October 9, 2018
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal EffectsJonathan E Schoenhals, Taylor R Cushman, Hampartsoum B Barsoumian, et al.
Cancer Letters|May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cellsAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune ResponsesMauricio S Caetano, Ahmed I Younes, Hampartsoum B Barsoumian, et al.
Frontiers in Immunology|March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and MicroenvironmentHari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 11, 2019
Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United StatesVivek Verma, Waqar Haque, Taylor R Cushman, et al.
Journal of Thoracic Disease|March 30, 2018
Combining radiation plus immunotherapy to improve systemic immune responseTaylor R Cushman, Daniel Gomez, Rachit Kumar, et al.
Future Oncology (London, England)|February 19, 2020
Management and outcomes of primary anorectal melanoma in the United StatesHari Menon, Roshal R Patel, Taylor R Cushman, et al.
Clinical Lung Cancer|October 11, 2020
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United StatesTaylor R Cushman, Bernard Jones, David Akhavan, et al.
Future Oncology (London, England)|April 18, 2020
Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalitiesHari Menon, Roshal R Patel, Ethan B Ludmir, et al.
Clinical Lung Cancer|August 17, 2018
Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung CancerVivek Verma, Caitlin A Schonewolf, Taylor R Cushman, et al.
Frontiers in Immunology|October 9, 2018
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal EffectsJonathan E Schoenhals, Taylor R Cushman, Hampartsoum B Barsoumian, et al.
Cancer Letters|May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cellsAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune ResponsesMauricio S Caetano, Ahmed I Younes, Hampartsoum B Barsoumian, et al.
Frontiers in Immunology|March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and MicroenvironmentHari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Pageof 3